Jiro Inagaki

2.2k total citations · 1 hit paper
90 papers, 1.5k citations indexed

About

Jiro Inagaki is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jiro Inagaki has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 38 papers in Oncology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jiro Inagaki's work include Hematopoietic Stem Cell Transplantation (37 papers), Acute Lymphoblastic Leukemia research (20 papers) and Acute Myeloid Leukemia Research (17 papers). Jiro Inagaki is often cited by papers focused on Hematopoietic Stem Cell Transplantation (37 papers), Acute Lymphoblastic Leukemia research (20 papers) and Acute Myeloid Leukemia Research (17 papers). Jiro Inagaki collaborates with scholars based in Japan, United States and United Kingdom. Jiro Inagaki's co-authors include Victorio Rodriguez, Gerald P. Bodey, Reiji Fukano, Jun Okamura, Hideshi Sugiura, Hisashi Iwata, Hirohisa Katagiri, Mitsuru Takahashi, Maiko Noguchi and N Horikoshi and has published in prestigious journals such as Blood, Cancer and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jiro Inagaki

87 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causes of death in cancer patients

1974 476 citations Jiro Inagaki et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiro Inagaki Japan	19	496	451	226	209	204	90	1.5k
Ka Wah Chan United States	24	876 1.8×	413 0.9×	178 0.8×	302 1.4×	203 1.0×	67	1.8k
Dirk Schrijvers Belgium	21	771 1.6×	800 1.8×	223 1.0×	135 0.6×	337 1.7×	62	2.3k
John Lazarchick United States	25	883 1.8×	228 0.5×	285 1.3×	87 0.4×	260 1.3×	135	2.0k
Françoise Mazingue France	22	533 1.1×	267 0.6×	131 0.6×	512 2.4×	113 0.6×	63	1.4k
Adam Gassas Canada	19	460 0.9×	238 0.5×	128 0.6×	235 1.1×	185 0.9×	84	1.1k
Donald J. Higby United States	19	543 1.1×	627 1.4×	237 1.0×	120 0.6×	197 1.0×	48	1.4k
Amita Trehan India	23	687 1.4×	350 0.8×	154 0.7×	609 2.9×	263 1.3×	232	2.1k
Roberto Dall’Amico Italy	22	658 1.3×	233 0.5×	284 1.3×	113 0.5×	259 1.3×	62	2.0k
Yahya Büyükaşık Türkiye	20	818 1.6×	334 0.7×	130 0.6×	113 0.5×	151 0.7×	164	1.6k
Georg Stüssi Switzerland	25	981 2.0×	343 0.8×	311 1.4×	241 1.2×	94 0.5×	96	2.1k

Countries citing papers authored by Jiro Inagaki

Since Specialization

Citations

This map shows the geographic impact of Jiro Inagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Inagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Inagaki more than expected).

Fields of papers citing papers by Jiro Inagaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Inagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Inagaki. The network helps show where Jiro Inagaki may publish in the future.

Co-authorship network of co-authors of Jiro Inagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Inagaki. A scholar is included among the top collaborators of Jiro Inagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Inagaki. Jiro Inagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inagaki, Jiro, Maiko Noguchi, & Reiji Fukano. (2020). Prognosis of pediatric patients with anicteric and late‐onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 67(8). e28412–e28412. 1 indexed citations

Kudo, Kazuko, Miho Maeda, Nobuhiro Suzuki, et al.. (2018). Hematopoietic Stem Cell Transplantation in Children with Refractory Langerhans Cell Histiocytosis. Blood. 132(Supplement 1). 4657–4657. 2 indexed citations

Inagaki, Jiro, Reiji Fukano, Maiko Noguchi, & Jun Okamura. (2017). A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies. International Journal of Hematology. 105(5). 676–685. 3 indexed citations

Sakaguchi, Hirotoshi, Nobuhiro Watanabe, Kimikazu Matsumoto, et al.. (2016). Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study. Biology of Blood and Marrow Transplantation. 22(12). 2226–2234. 12 indexed citations

Inagaki, Jiro, Hiroshi Moritake, Takuro Nishikawa, et al.. (2015). Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(11). 1973–1980. 27 indexed citations

Inagaki, Jiro, Yuichi Kodama, Reiji Fukano, Maiko Noguchi, & Jun Okamura. (2015). Mycophenolate mofetil for treatment of steroid‐refractory acute graft‐versus‐host disease after pediatric hematopoietic stem cell transplantation. Pediatric Transplantation. 19(6). 652–658. 17 indexed citations

Okamoto, Yasuhiro, Jiro Inagaki, Shuichi Ozono, et al.. (2015). Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia. International Journal of Hematology. 103(2). 202–209. 4 indexed citations

Kato, Motohiro, Daiichiro Hasegawa, Katsuyoshi Koh, et al.. (2014). Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation. British Journal of Haematology. 168(4). 564–570. 13 indexed citations

Fukano, Reiji, Nobuhiro Ito, Kentaro Nakashima, et al.. (2014). Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL. Pediatric Transplantation. 18(5). 518–523. 4 indexed citations

10.

Inagaki, Jiro, Reiji Fukano, Takuro Nishikawa, et al.. (2012). Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. Pediatric Blood & Cancer. 60(1). 116–120. 25 indexed citations

11.

Inagaki, Jiro, et al.. (2007). Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children. Bone Marrow Transplantation. 41(6). 571–577. 26 indexed citations

12.

Inagaki, Jiro, et al.. (2006). Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin. Pediatric Transplantation. 11(2). 180–186. 2 indexed citations

13.

Laskar, M, Masaiwa Inoue, Jiro Inagaki, et al.. (2005). Effect of room temperature on percentage finger systolic blood pressure response to finger cooling. European Journal of Applied Physiology. 94(5-6). 626–632. 2 indexed citations

14.

Yumura‐Yagi, Keiko, Masaki Inoue, Naoki Sakata, et al.. (2005). Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience. Bone Marrow Transplantation. 36(4). 307–313. 6 indexed citations

15.

Inagaki, Jiro, Masahiro Yasui, Naoki Sakata, et al.. (2005). Successful Treatment of Chemoresistant Stage 3 Neuroblastoma Using Irinotecan as a Single Agent. Journal of Pediatric Hematology/Oncology. 27(11). 604–606. 8 indexed citations

16.

Katagiri, Hirohisa, Mitsuru Takahashi, Jiro Inagaki, et al.. (1999). Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin. Cancer. 86(3). 533–537. 63 indexed citations

17.

Katagiri, Hirohisa, Mitsuru Takahashi, Jiro Inagaki, et al.. (1998). Clinical results of nonsurgical treatment for spinal metastases. International Journal of Radiation Oncology*Biology*Physics. 42(5). 1127–1132. 102 indexed citations

18.

Goto, Tatsuhiko, et al.. (1991). Septicemia in Patients with Solid Cancers in a Japanese Cancer Hospital—The Significance of Candidemia for Cancer Patients. Japanese Journal of Clinical Oncology. 21(1). 52–8. 4 indexed citations

19.

Inoue, Kengo, et al.. (1985). [In vitro evaluation of anticancer drugs and retrospective clinical trials with the human tumor cloning system].. PubMed. 20(1). 59–65. 1 indexed citations

20.

Inoue, Katsuhiro, Hideaki Miyamoto, Jiro Inagaki, et al.. (1984). [Colony growth by various malignant cells of cancer patients on in vitro colony assay].. PubMed. 19(7). 1456–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact